OPTION PERIOD ONE (1): TASK AREA B.2. - COHORT EXAM 4 AND EXAM CLOSEOUT FOR JACKSON HEART STUDY (JHS) COORDINATING CENTER (CC).

选择期一 (1):任务领域 B.2。

基本信息

  • 批准号:
    10809556
  • 负责人:
  • 金额:
    $ 286.87万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-06-13 至 2023-12-12
  • 项目状态:
    已结题

项目摘要

The Jackson Heart Study (JHS), initiated in 1998, is a longitudinal investigation of genetic and environmental risk factors associated with the disproportionate burden of cardiovascular disease (CVD) in African-Americans. In addition, the JHS performs a variety of community education and outreach activities to promote healthy lifestyles and reduce disease risk burden. It also conducts college undergraduate and graduate-level training programs and high school science and math enrichment programs to prepare and encourage underrepresented minority students to pursue biomedical careers. (www.jacksonheartstudy.org/). The JHS represents an expansion of the Jackson Field Center of the Atherosclerosis Risk in Communities (ARIC) study (www2.cscc.unc.edu/aric/), to broaden data collection in an African- American population and to increase access to and participation of African American populations and scientists in biomedical research and professions. The study recruited 5306 African-American residents, including 3,732 residents also enrolled in ARIC, living in the Jackson, MS, metropolitan area of Hinds, Madison, and Rankin Counties. Enrolled JHS participants, initially aged 20 - 90 years, received three back-to-back examinations (Exam 1, 2000-04; Exam 2, 2005-08; and Exam 3, 2009-13) and have been contacted annually. Findings on the rich set of data on physical, behavioral, genetic, and psychosocial factors have been presented in over 345 publications as of the end of 2016. Participant exams have produced extensive longitudinal data on traditional and putative CVD risk factors, socioeconomic and sociocultural factors, and biochemical analytes; and measures of subclinical disease from echocardiography, cardiac magnetic resonance imaging (MRI), and computed tomography (CT) scans of the heart, aorta, and abdomen. Stored biological samples have been assayed for putative biochemical risk factors and stored for future research. DNA has been extracted and lymphocytes cryopreserved for study of candidate genes, genome-wide scanning, expression, and other –omics investigations. The study included a nested component of 428 families with mean family size of 5 at baseline; today 331 families with at least 1 living member still actively participate. Participation of the surviving cohort has been high: 80% (N=4205) and 72% (N=3820) at each of the two respective follow-up examinations. Today the average cohort age is 68 years. Since baseline, cohort members have also been contacted every 12 months to obtain information on vital status, current residence, major illness or injury, and hospitalizations occurring between contacts to identify incident clinical CVD events of interest. Due to JHS’ shared cohort membership with ARIC, the two studies cooperate with each other on events validation.
杰克逊心脏研究(JHS)于1998年启动,是1998年的纵向,在非裔美国人中,心血管疾病(CVD)的纵向负担,JHS还进行了各种社区教育和外展活动,以促进健康的生活方式和疾病。风险负担。 社区动脉粥样硬化风险(ARIC)研究(www2.cscc.unc.edu/)Aden数据收集的JHS杰克逊领域的JHS麻风雨专业人士。 2,2005-08; 3,2009 - 13年),截至2016年底,已经在345个出版物中介绍了有关物理,行为,遗传和心理心理因素的丰富数据。 参与者的检查纵向数据,从超声心动摄影,心脏磁共振(MRI)扫描(CT)心脏,Aorta,Aorta和Abdomecorples中,来自超临床疾病的生化分析物以及对亚临床疾病的措施已经进行了方形的风险因素,并储存了未来的研究,并为候选基因的研究,基因组扫描,表达,Andics投资提供了淋巴细胞的淋巴细胞。 TICIPATE的参与度很高:在两个随访期中,每两个随访的年龄都有80%(n = 4205)(n = 4205)(n = 3820)。有关生命状况,当前居住,重大疾病或伤害以及住院的信息,以识别互联网的临床CVD事件。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

April P Carson其他文献

April P Carson的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('April P Carson', 18)}}的其他基金

OPTION PERIOD ONE (1): TASK AREA B.2. - COHORT EXAM 4 AND EXAM CLOSEOUT FOR JACKSON HEART STUDY (JHS) FIELD CENTER (FC).
选择期一 (1):任务领域 B.2。
  • 批准号:
    10787967
  • 财政年份:
    2021
  • 资助金额:
    $ 286.87万
  • 项目类别:
Return of Genomic Results and Estimating Penetrance in Population-Based Cohorts
基因组结果的返回和基于人群的队列中外显率的估计
  • 批准号:
    10448274
  • 财政年份:
    2019
  • 资助金额:
    $ 286.87万
  • 项目类别:
Prioritizing county-level social determinants that contribute to the greater burden of diabetes and hypertension in the US
优先考虑导致美国糖尿病和高血压负担加重的县级社会决定因素
  • 批准号:
    10201403
  • 财政年份:
    2017
  • 资助金额:
    $ 286.87万
  • 项目类别:
Prioritizing county-level social determinants that contribute to the greater burden of diabetes and hypertension in the US
优先考虑导致美国糖尿病和高血压负担加重的县级社会决定因素
  • 批准号:
    9433007
  • 财政年份:
    2017
  • 资助金额:
    $ 286.87万
  • 项目类别:
The Role of Nontraditional Glycemic Markers in Diabetes and Albuminuria
非传统血糖标志物在糖尿病和蛋白尿中的作用
  • 批准号:
    9028606
  • 财政年份:
    2013
  • 资助金额:
    $ 286.87万
  • 项目类别:
The Role of Nontraditional Glycemic Markers in Diabetes and Albuminuria
非传统血糖标志物在糖尿病和蛋白尿中的作用
  • 批准号:
    8508005
  • 财政年份:
    2013
  • 资助金额:
    $ 286.87万
  • 项目类别:

相似国自然基金

基于机器学习和影像学多参数融合的心血管不良事件风险预测模型研究
  • 批准号:
    82370513
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
GNB3联合光谱CT冠周脂肪组学预警ACS后心血管不良事件的模型构建
  • 批准号:
    82302186
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
基于人工智能和多模态信息预测复杂下肢动脉病变术后不良事件的算法机制研究
  • 批准号:
    82370499
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
基于效用错位视角的医疗不良事件管理政策的引导体系优化研究
  • 批准号:
    72304012
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
基于真实世界数据的药物相互作用相关不良事件风险评估及其管理策略研究
  • 批准号:
    72304010
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

OPTION PERIOD ONE (1): TASK AREA B.2. - COHORT EXAM 4 AND EXAM CLOSEOUT FOR JACKSON HEART STUDY (JHS) COORDINATING CENTER (CC).
选择期一 (1):任务领域 B.2。
  • 批准号:
    10498454
  • 财政年份:
    2021
  • 资助金额:
    $ 286.87万
  • 项目类别:
OPTION PERIOD ONE (1): TASK AREA B.2. - COHORT EXAM 4 AND EXAM CLOSEOUT FOR JACKSON HEART STUDY (JHS) FIELD CENTER (FC).
选择期一 (1):任务领域 B.2。
  • 批准号:
    10498463
  • 财政年份:
    2021
  • 资助金额:
    $ 286.87万
  • 项目类别:
OPTION PERIOD ONE (1): TASK AREA B.2. - COHORT EXAM 4 AND EXAM CLOSEOUT FOR JACKSON HEART STUDY (JHS) FIELD CENTER (FC).
选择期一 (1):任务领域 B.2。
  • 批准号:
    10787967
  • 财政年份:
    2021
  • 资助金额:
    $ 286.87万
  • 项目类别:
MULTI-ETHNIC STUDY OF ATHEROSCLEROSIS (MESA) COORDINATING CENTER (CC) - TASK AREA B EXAM 7
多民族动脉粥样硬化研究 (MESA) 协调中心 (CC) - 任务领域 B 考试 7
  • 批准号:
    10470548
  • 财政年份:
    2019
  • 资助金额:
    $ 286.87万
  • 项目类别:
Adipokines and Barrett's Esophagus
脂肪因子和巴雷特食管
  • 批准号:
    8100819
  • 财政年份:
    2010
  • 资助金额:
    $ 286.87万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了